Literature DB >> 19342641

Langerhans cells are not required for the CD8 T cell response to epidermal self-antigens.

Laura S Bursch1, Benjamin E Rich, Kristin A Hogquist.   

Abstract

Langerhans cells (LC) are APC that reside at the barrier surfaces. Mice expressing an OVA peptide in the epidermis (K14-OVAp) were used to study CD8(+) T cell responses to an epidermal self-Ag. Earlier results suggested that LC were the predominant APC, inducing a robust T cell response and autoimmunity. In this study, we used a whole protein model system, the K14-mOVA mouse, in which a transmembrane form of OVA was expressed in keratinocytes. In contrast to K14-OVAp mice, T cells in K14-mOVA mice were activated, but did not expand and instead died by apoptosis. Furthermore, in double-transgenic mice expressing both mOVA and OVAp, robust OT-I expansion occurred, indicating that tolerance to this Ag is not dominant and was due to lack of activating signals. We sought to identify the relevant APC in K14 mice using bone marrow chimeras and found that radioresistant cells (presumably LC) were able to cross-present the OVA Ag from keratinocytes to naive T cells in the lymph node. However, use of LC-deficient mice indicated that LC were not required for the expansion of OT-I in K14-OVAp or the deletion of OT-I in K14-mOVA mice. These data suggest that radioresistant non-LC present self-Ag in K14-OVAp mice and drive a robust CD8 T cell response.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19342641      PMCID: PMC2722807          DOI: 10.4049/jimmunol.0803656

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  55 in total

1.  Cutting edge: intravenous soluble antigen is presented to CD4 T cells by CD8- dendritic cells, but cross-presented to CD8 T cells by CD8+ dendritic cells.

Authors:  J L Pooley; W R Heath; K Shortman
Journal:  J Immunol       Date:  2001-05-01       Impact factor: 5.422

2.  Impact of negative selection on the T cell repertoire reactive to a self-peptide: a large fraction of T cell clones escapes clonal deletion.

Authors:  C Bouneaud; P Kourilsky; P Bousso
Journal:  Immunity       Date:  2000-12       Impact factor: 31.745

3.  Peripheral antigen display by lymph node stroma promotes T cell tolerance to intestinal self.

Authors:  Je-Wook Lee; Mathieu Epardaud; Jing Sun; Jessica E Becker; Alexander C Cheng; Ai-ris Yonekura; Joan K Heath; Shannon J Turley
Journal:  Nat Immunol       Date:  2006-12-31       Impact factor: 25.606

4.  Conditioning of Langerhans cells induced by a primary CD8 T cell response to self-antigen in vivo.

Authors:  Dita Mayerova; Liangchun Wang; Laura S Bursch; Kristin A Hogquist
Journal:  J Immunol       Date:  2006-04-15       Impact factor: 5.422

5.  Skin antigens in the steady state are trafficked to regional lymph nodes by transforming growth factor-beta1-dependent cells.

Authors:  H Hemmi; M Yoshino; H Yamazaki; M Naito; T Iyoda; Y Omatsu; S Shimoyama; J J Letterio; T Nakabayashi; H Tagaya; T Yamane; M Ogawa; S Nishikawa; K Ryoke; K Inaba; S Hayashi; T Kunisada
Journal:  Int Immunol       Date:  2001-05       Impact factor: 4.823

6.  Transgenic expression of dominant-negative Fas-associated death domain protein in beta cells protects against Fas ligand-induced apoptosis and reduces spontaneous diabetes in nonobese diabetic mice.

Authors:  Janette Allison; Helen E Thomas; Tara Catterall; Thomas W H Kay; Andreas Strasser
Journal:  J Immunol       Date:  2005-07-01       Impact factor: 5.422

7.  Langerhans cells cross-present antigen derived from skin.

Authors:  Patrizia Stoitzner; Christoph H Tripp; Andreas Eberhart; Kylie M Price; Jae Y Jung; Laura Bursch; Franca Ronchese; Nikolaus Romani
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-03       Impact factor: 11.205

8.  Migratory Langerhans cells in mouse lymph nodes in steady state and inflammation.

Authors:  Patrizia Stoitzner; Christoph H Tripp; Patrice Douillard; Sem Saeland; Nikolaus Romani
Journal:  J Invest Dermatol       Date:  2005-07       Impact factor: 8.551

9.  T cells with low avidity for a tissue-restricted antigen routinely evade central and peripheral tolerance and cause autoimmunity.

Authors:  Dietmar Zehn; Michael J Bevan
Journal:  Immunity       Date:  2006-08-03       Impact factor: 31.745

10.  CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo.

Authors:  J M den Haan; S M Lehar; M J Bevan
Journal:  J Exp Med       Date:  2000-12-18       Impact factor: 14.307

View more
  20 in total

1.  Epidermal Langerhans cells tune skin reactivity to contact allergens.

Authors:  Mark C Udey
Journal:  J Clin Invest       Date:  2012-04-23       Impact factor: 14.808

2.  Langerhans cells are precommitted to immune tolerance induction.

Authors:  Elena Shklovskaya; Brendan J O'Sullivan; Lai Guan Ng; Ben Roediger; Ranjeny Thomas; Wolfgang Weninger; Barbara Fazekas de St Groth
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-17       Impact factor: 11.205

Review 3.  In vivo function of Langerhans cells and dermal dendritic cells.

Authors:  Daniel H Kaplan
Journal:  Trends Immunol       Date:  2010-10-28       Impact factor: 16.687

4.  TLR7 enables cross-presentation by multiple dendritic cell subsets through a type I IFN-dependent pathway.

Authors:  Jason Z Oh; Jonathan S Kurche; Matthew A Burchill; Ross M Kedl
Journal:  Blood       Date:  2011-08-02       Impact factor: 22.113

Review 5.  Mechanisms maintaining peripheral tolerance.

Authors:  Daniel L Mueller
Journal:  Nat Immunol       Date:  2009-12-17       Impact factor: 25.606

6.  Dendritic cell migration limits the duration of CD8+ T-cell priming to peripheral viral antigen.

Authors:  Amanda M Schell; Erica L Granger; Frank Koczot; Matthew A Fischer; Christopher C Norbury
Journal:  J Virol       Date:  2010-01-20       Impact factor: 5.103

7.  Engineering antigens for in situ erythrocyte binding induces T-cell deletion.

Authors:  Stephan Kontos; Iraklis C Kourtis; Karen Y Dane; Jeffrey A Hubbell
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-17       Impact factor: 11.205

Review 8.  Cross-presentation by dendritic cells.

Authors:  Olivier P Joffre; Elodie Segura; Ariel Savina; Sebastian Amigorena
Journal:  Nat Rev Immunol       Date:  2012-07-13       Impact factor: 53.106

Review 9.  Antigen presentation by Langerhans cells.

Authors:  Botond Z Igyártó; Daniel H Kaplan
Journal:  Curr Opin Immunol       Date:  2012-12-12       Impact factor: 7.486

10.  CD207+ CD103+ dermal dendritic cells cross-present keratinocyte-derived antigens irrespective of the presence of Langerhans cells.

Authors:  Sandrine Henri; Lionel Franz Poulin; Samira Tamoutounour; Laurence Ardouin; Martin Guilliams; Béatrice de Bovis; Elisabeth Devilard; Christophe Viret; Hiroaki Azukizawa; Adrien Kissenpfennig; Bernard Malissen
Journal:  J Exp Med       Date:  2009-12-28       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.